Neo-Synalar: payments to doctors
Payments that named Neo-Synalar as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $201K
- Providers
- 918
- Transactions
- 3,386
- Average per transaction
- $59
The per-transaction average — $59 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 918 providers the average total is $219, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | $201,155 | 100.0% |